Early stage drug developer Cytometix raises $1.9M in equity

Cytometix Inc. has raised $1.9 million in equity to further development of a drug that treats pain, according to a Securities and Exchange Commission filing. The company plans to use the funding to take the drug to the point at which it can file an Investigational New Drug application with federal regulators, CEO Lane Brostrom […]